HLB Pharmaceutical Public offering
HLB제약 · Closed
Offer price₩5,650Final terms filed
Shares offered10,762,332
Offering size₩60.8bn
SubscriptionThu Sep 10
HLB Pharmaceutical (HLB제약) public offering subscription runs Thu Sep 10 to Fri Sep 11. The offer price is ₩5,650 for 10,762,332 shares, about ₩60.8bn in total. Underwriters: Korea Investment & Securities, Hana Securities, Hanyang Securities. Payment and refund date: Fri Sep 18.
Underwriters
| Role | Broker | Shares | Amount |
|---|---|---|---|
| Lead | Korea Investment & Securities | 6,457,400 | ₩36.5bn |
| Co-manager | Hana Securities | 3,228,699 | ₩18.2bn |
| Co-manager | Hanyang Securities | 1,076,233 | ₩6.1bn |
HLB Pharmaceutical public offering FAQ
- When is the HLB Pharmaceutical public offering subscription?
- Thu Sep 10 to Fri Sep 11 (Korea time). Refunds and payment are on Fri Sep 18.
- What is the HLB Pharmaceutical public offering price?
- ₩5,650 per share.
From the DART registration statement (equity securities). Book-building and subscription results are added once the final terms filing and issuance result report are published; listing dates are not included. Not investment advice.